First-line Pembrolizumab Plus Lenvatinib for Advanced Non–clear-cell Renal Cell Carcinoma: Updated Results from the Phase 2 KEYNOTE-B61 Trial

作者：Martin H. Voss, Howard Gurney, Vagif Atduev, Cristina Suárez, Miguel Ángel Climent, David Pook, Piotr Tomczak, Philippe Barthélémy, Jae‐Lyun Lee, Taron Nalbandian, V.P. Stus, Thomas Ferguson, Paweł Wiechno, Erhan Gökmen, Louis Lacombe, Craig Gedye, Jerry Cornell, Manish Sharma, Joseph E. Burgents, Laurence Albigès · 发表于：European Urology · 年份：2025 · DOI：10.1016/j.eururo.2025.05.019 · 被引用次数：13 · 研究领域：Renal cell carcinoma treatment、Bladder and Urothelial Cancer Treatments、Cancer Research and Treatments